These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9772047)

  • 1. Clostridium difficile colitis: factors influencing treatment failure and relapse--a prospective evaluation.
    Nair S; Yadav D; Corpuz M; Pitchumoni CS
    Am J Gastroenterol; 1998 Oct; 93(10):1873-6. PubMed ID: 9772047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole.
    Musher DM; Aslam S; Logan N; Nallacheru S; Bhaila I; Borchert F; Hamill RJ
    Clin Infect Dis; 2005 Jun; 40(11):1586-90. PubMed ID: 15889354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical spectrum of Clostridium difficile colitis in immunocompromised patients.
    Schweitzer MA; Sweiss I; Silver DL; Stellato TA
    Am Surg; 1996 Jul; 62(7):603-7; discussion 607-8. PubMed ID: 8651560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of clinical and microbiological response to treatment of Clostridium difficile-associated disease with metronidazole and vancomycin.
    Al-Nassir WN; Sethi AK; Nerandzic MM; Bobulsky GS; Jump RL; Donskey CJ
    Clin Infect Dis; 2008 Jul; 47(1):56-62. PubMed ID: 18491964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for severity and relapse of pseudomembranous colitis in an elderly population.
    Moshkowitz M; Ben-Baruch E; Kline Z; Shimoni Z; Niven M; Konikoff F
    Colorectal Dis; 2007 Feb; 9(2):173-7. PubMed ID: 17223943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of Clostridium difficile infection in the relapse of ulcerative colitis].
    Vilalta Castel E; Alcázar Montero MS; Navarro Gaspar C; Gimeno Aranguez M
    An Med Interna; 2002 Dec; 19(12):637-9. PubMed ID: 12593034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Relapsing infections with Clostridium difficile].
    Visser WE; Dingemans-Dumas AM; Bac DJ
    Ned Tijdschr Geneeskd; 2005 Oct; 149(43):2381-5. PubMed ID: 16277125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada.
    Pepin J; Alary ME; Valiquette L; Raiche E; Ruel J; Fulop K; Godin D; Bourassa C
    Clin Infect Dis; 2005 Jun; 40(11):1591-7. PubMed ID: 15889355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of Clostridium difficile-associated disease treated with metronidazole or vancomycin before and after the emergence of NAP1/027.
    Pépin J; Valiquette L; Gagnon S; Routhier S; Brazeau I
    Am J Gastroenterol; 2007 Dec; 102(12):2781-8. PubMed ID: 17900327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clostridium difficile colitis: an increasing hospital-acquired illness.
    Jobe BA; Grasley A; Deveney KE; Deveney CW; Sheppard BC
    Am J Surg; 1995 May; 169(5):480-3. PubMed ID: 7747823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metronidazole: an alternate therapy for antibiotic-associated colitis.
    Cherry RD; Portnoy D; Jabbari M; Daly DS; Kinnear DG; Goresky CA
    Gastroenterology; 1982 May; 82(5 Pt 1):849-51. PubMed ID: 7060906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic criteria in Clostridium difficile colitis.
    Ramaswamy R; Grover H; Corpuz M; Daniels P; Pitchumoni CS
    Am J Gastroenterol; 1996 Mar; 91(3):460-4. PubMed ID: 8633491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease.
    McFarland LV; Elmer GW; Surawicz CM
    Am J Gastroenterol; 2002 Jul; 97(7):1769-75. PubMed ID: 12135033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity.
    Zar FA; Bakkanagari SR; Moorthi KM; Davis MB
    Clin Infect Dis; 2007 Aug; 45(3):302-7. PubMed ID: 17599306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Symptomatic relapse after oral vancomycin therapy of antibiotic-associated pseudomembranous colitis.
    Bartlett JG; Tedesco FJ; Shull S; Lowe B; Chang T
    Gastroenterology; 1980 Mar; 78(3):431-4. PubMed ID: 7053190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent Clostridium difficile infection: a review of risk factors, treatments, and outcomes.
    Johnson S
    J Infect; 2009 Jun; 58(6):403-10. PubMed ID: 19394704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of infections associated with Clostridium difficile].
    Szczesny A; Martirosian G
    Wiad Lek; 2003; 56(5-6):278-82. PubMed ID: 14526488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The changing face of Clostridium difficile: what treatment options remain?
    Shen EP; Surawicz CM
    Am J Gastroenterol; 2007 Dec; 102(12):2789-92. PubMed ID: 18042108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective, randomized inpatient study of oral metronidazole versus oral metronidazole and rifampin for treatment of primary episode of Clostridium difficile-associated diarrhea.
    Lagrotteria D; Holmes S; Smieja M; Smaill F; Lee C
    Clin Infect Dis; 2006 Sep; 43(5):547-52. PubMed ID: 16886144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pseudomembraneous clostridium after autologous bone marrow transplantation.
    Kavan P; Sochor M; Nyc O; Lochmann O; Koutecky J; Skala PJ; McClain LK
    Bone Marrow Transplant; 1998 Mar; 21(5):521-3. PubMed ID: 9535046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.